17/B, Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai 400 093 India Tel.: (91-22) 6645 5645 Fax.: (91-22) 6645 5685 |  |
FOR IMMEDIATE RELEASE
Sun Pharma Announces Expiration of Subsequent Offering Period
Mumbai, India: September 29, 2010: Sun Pharmaceutical Industries Ltd. (Sun) (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced the expiration of the subsequent offering period to the tender offer by Sun’s subsidiary Alkaloida Chemical Company Exclusive Group Ltd (Alakloida) for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). Sun has been informed by Computershare, the Depositary for the Offer, that as of 12:00 midnight New York City time on September 28, 2010, a total of 29,382 Ordinary Shares had been tendered pursuant to the tender offer representing approximately 0.07% of the outstanding Ordinary Shares. During the pendency of the subsequent offering period, no additional shares have been tendered. All tendered Ordinary Shares were accepted for payment.
About Sun Pharma
Established in 1983, listed since 1994 and headquartered in India, Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.
Contacts
| Uday Baldota | Mira Desai | ||
| Tel | +91 22 6645 5645, Xtn 605 | Tel | +91 22 6645 5645, Xtn 606 |
| Tel Direct | +91 22 66455605 | Tel Direct | +91 22 66455606 |
| Mobile | +91 98670 10529 | Mobile | +91 98219 23797 |
| E mail | uday.baldota@sunpharma.com | E mail | mira.desai@sunpharma.com |
| Brunswick Group for Sun Pharma | MacKenzie Partners | ||
| Erin Becker/Nicki Kahner | Robert Marese | ||
| +1 212 333 3810 | +1 212 929 5500 | ||
| Arad Communications for Sun Pharma | Greenhill | ||
| Irit Radia | Ashish Contractor | ||
| +972-54-6699311 | +1 212 389 1537 | ||
Registered Office : SPARC, Tandalja, Vadodara – 390 020. India
Corporate Office : Acme Plaza, Andheri – Kurla Road, Andheri (East), Mumbai – 400 059. India